[ad_1] NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC). Such investors are advised to contact Danielle Peyton at […]
Tag: Pomerantz LLP
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chegg, Inc.- CHGG
[ad_1] NEW YORK, Sept. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG). Such investors are advised to contact Danielle Peyton at […]
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against GitLab Inc.
[ad_1] NEW YORK, Sept. 9, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against GitLab Inc. (“GitLab” or the “Company”) (NASDAQ: GTLB). Such investors are advised to contact Danielle Peyton at [email protected] […]
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines
[ad_1] NEW YORK, Sept. 9, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE) and certain officers. The class action, filed […]
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chegg, Inc.- CHGG
[ad_1] NEW YORK, Sept. 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG). Such investors are advised to contact Danielle Peyton at [email protected] or […]
